Brigade Capital Management LP Lowered Oclaro (Call) (OCLR) Holding; Evogene Limited Ord (EVGN) Shorts Decreased By 23.17%

February 16, 2018 - By Louis Casey

Evogene Limited Ord (NASDAQ:EVGN) had a decrease of 23.17% in short interest. EVGN’s SI was 12,600 shares in February as released by FINRA. Its down 23.17% from 16,400 shares previously. With 8,500 avg volume, 2 days are for Evogene Limited Ord (NASDAQ:EVGN)’s short sellers to cover EVGN’s short positions. The SI to Evogene Limited Ord’s float is 0.06%. The stock decreased 1.83% or $0.07 during the last trading session, reaching $3.75. About 7,737 shares traded. Evogene Ltd. (NASDAQ:EVGN) has declined 23.47% since February 16, 2017 and is downtrending. It has underperformed by 40.17% the S&P500.

Brigade Capital Management Lp decreased Oclaro Inc (Call) (OCLR) stake by 33.33% reported in 2017Q3 SEC filing. Brigade Capital Management Lp sold 500,000 shares as Oclaro Inc (Call) (OCLR)’s stock declined 22.87%. The Brigade Capital Management Lp holds 1.00 million shares with $8.63 million value, down from 1.50 million last quarter. Oclaro Inc (Call) now has $1.16B valuation. The stock increased 1.11% or $0.075 during the last trading session, reaching $6.865. About 2.19 million shares traded. Oclaro, Inc. (NASDAQ:OCLR) has risen 92.74% since February 16, 2017 and is uptrending. It has outperformed by 76.04% the S&P500.

Evogene Ltd., a biotechnology company, focuses on the enhancement of crop productivity and performance in the United States and Germany. The company has market cap of $94.55 million. It operates through two divisions, Evogene and Evofuel. It currently has negative earnings. The Evogene segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance.

Investors sentiment decreased to 1.28 in 2017 Q3. Its down 0.23, from 1.51 in 2017Q2. It is negative, as 43 investors sold OCLR shares while 60 reduced holdings. 39 funds opened positions while 93 raised stakes. 115.55 million shares or 1.25% more from 114.12 million shares in 2017Q2 were reported. Federated Investors Pa holds 0.01% or 450,000 shares. Huntington Natl Bank holds 0% or 4,961 shares. Parkside Commercial Bank Tru invested in 0% or 80 shares. Perritt Mngmt invested in 0.11% or 49,050 shares. Northern Tru reported 0% in Oclaro, Inc. (NASDAQ:OCLR). The Michigan-based World Asset Mgmt has invested 0% in Oclaro, Inc. (NASDAQ:OCLR). 2,000 are held by Carroll Assoc. Century Inc reported 0% stake. 562,500 were reported by Credit Suisse Ag. 17,105 were accumulated by Sei Invs. Fmr Ltd Com has 0% invested in Oclaro, Inc. (NASDAQ:OCLR). Cubist Systematic Strategies Ltd Company has invested 0.1% in Oclaro, Inc. (NASDAQ:OCLR). Bancshares Hapoalim Bm has invested 0.17% in Oclaro, Inc. (NASDAQ:OCLR). Falcon Point Capital Ltd Liability holds 12,382 shares. Millrace Asset Gru Inc invested in 217,787 shares.

Among 18 analysts covering Oclaro Inc (NASDAQ:OCLR), 13 have Buy rating, 1 Sell and 4 Hold. Therefore 72% are positive. Oclaro Inc had 51 analyst reports since August 18, 2015 according to SRatingsIntel. The stock has “Buy” rating by M Partners on Tuesday, February 6. The rating was upgraded by B. Riley & Co on Wednesday, November 4 to “Buy”. The stock of Oclaro, Inc. (NASDAQ:OCLR) earned “Outperform” rating by Northland Capital on Tuesday, August 18. Northland Capital maintained Oclaro, Inc. (NASDAQ:OCLR) on Friday, September 15 with “Buy” rating. The rating was maintained by Stifel Nicolaus on Wednesday, August 23 with “Buy”. As per Monday, September 11, the company rating was maintained by Piper Jaffray. The rating was initiated by Craig Hallum with “Buy” on Thursday, December 3. Stifel Nicolaus maintained it with “Buy” rating and $8.5 target in Wednesday, January 24 report. The firm has “Buy” rating given on Thursday, July 13 by Cowen & Co. The firm has “Buy” rating by Stifel Nicolaus given on Tuesday, September 6.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: